Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,579.60
-19.40 (-0.75%)
Sep 12, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.06 trillion as of September 12, 2025. Its market cap has increased by 9.50% in one year.
Market Cap
1.06T
Enterprise Value
1.13T
Revenue
129.10B
Ranking
n/a
PE Ratio
55.57
Stock Price
2,579.60
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.06T, an increase of 86.88%. That is a compound annual growth rate of 30.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1,064.75B | -10.40% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,878.76B |
| Divi's Laboratories | 1,599.85B |
| Cipla | 1,271.89B |
| Apollo Hospitals Enterprise | 1,132.23B |
| Zydus Lifesciences | 1,051.26B |
| Fortis Healthcare | 732.31B |
| Alkem Laboratories | 651.39B |
| Aurobindo Pharma | 635.63B |